tiprankstipranks
Trending News
More News >
Fuji Pharma Co., Ltd. (JP:4554)
:4554
Japanese Market

Fuji Pharma Co., Ltd. (4554) Financial Statements

Compare
0 Followers

Fuji Pharma Co., Ltd. Financial Overview

Fuji Pharma Co., Ltd.'s market cap is currently ¥46.70B. The company's EPS TTM is ¥47.87; its P/E ratio is 15.55; and it has a dividend yield of 2.39%. Fuji Pharma Co., Ltd. is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 51.68B¥ 46.14B¥ 40.89B¥ 35.43B¥ 33.99B
Gross Profit¥ 19.29B¥ 17.84B¥ 16.52B¥ 14.56B¥ 14.75B
Operating Income¥ 4.99B¥ 3.88B¥ 3.86B¥ 3.78B¥ 3.35B
EBITDA¥ 8.30B¥ 12.15B¥ 7.54B¥ 6.52B¥ 5.53B
Net Income¥ 3.00B¥ 6.15B¥ 3.44B¥ 2.70B¥ 2.43B
Balance Sheet
Cash & Short-Term Investments¥ 7.25B¥ 4.58B¥ 2.32B¥ 3.55B¥ 10.20B
Total Assets¥ 93.41B¥ 90.00B¥ 85.33B¥ 75.54B¥ 64.24B
Total Debt¥ 30.94B¥ 29.25B¥ 28.95B¥ 24.57B¥ 18.66B
Net Debt¥ 23.69B¥ 24.67B¥ 26.62B¥ 21.02B¥ 8.46B
Total Liabilities¥ 46.49B¥ 44.44B¥ 44.16B¥ 39.73B¥ 31.56B
Stockholders' Equity¥ 46.91B¥ 45.56B¥ 41.17B¥ 35.80B¥ 32.68B
Cash Flow
Free Cash Flow¥ 3.82B¥ -221.00M¥ -1.98B¥ -13.08B¥ 2.10B
Operating Cash Flow¥ 5.80B¥ 4.15B¥ 1.92B¥ -658.00M¥ 5.99B
Investing Cash Flow¥ -4.22B¥ -1.66B¥ -5.24B¥ -11.27B¥ -2.35B
Financing Cash Flow¥ 954.00M¥ -435.00M¥ 1.92B¥ 5.09B¥ -5.43B
Currency in JPY

Fuji Pharma Co., Ltd. Earnings and Revenue History

Fuji Pharma Co., Ltd. Debt to Assets

Fuji Pharma Co., Ltd. Cash Flow

Fuji Pharma Co., Ltd. Forecast EPS vs Actual EPS